Organon makes another women’s health move with deal for endometriosis-focused Forendo November 11, 2021 Auto Bot BioPharma, biopharma nl, Clinical Trials, deals, New Jersey, Pharma, womens health 0 Organon’s proposed acquisition of Forendo Pharma is the company’s third the company since spinning out of Merck in the summer. Clinical-stage Forendo is developing a new, potentially more targeted approach to treating endometriosis.